Tetrahydroaminoacridine–Lecithin Combination Treatment in Patients with Intermediate-Stage Alzheimer's Disease: Results of a Canadian Double-Blind, Crossover, Multicenter Study

We studied the efficacy and safety of oral tetrahydroaminoacridine (THA) combined with lecithin in 52 patients with Alzheimer's disease. The maximal tolerated dose of THA (up to 100 mg per day) was determined during an eight-week titration period, after which the tolerated dose of THA or placeb...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 1990-05, Vol.322 (18), p.1272-1276
Hauptverfasser: Gauthier, Louise, Gauthier, Serge, Bouchard, Rémi, Lamontagne, Albert, Bailey, Peter, Bergman, Howard, Ratner, Jack, Tesfaye, Yoseph, Saint-Martin, Monique, Bacher, Yves, Carrier, Louise, Charbonneau, Roland, Clarfield, A. Mark, Collier, Brian, Dastoor, Dolly, Germain, Marcel, Kissel, Catherine, Krieger, Monique, Kushnir, Seymour, Masson, Hélène, Morin, Jacques, Nair, Vasavan, Neirinck, Leonard, Suissa, Samy
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!